Theravance Biopharma, Inc.·4

May 24, 6:18 PM ET

Shafer Bradford J 4

4 · Theravance Biopharma, Inc. · Filed May 24, 2021

Insider Transaction Report

Form 4
Period: 2021-05-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2021-05-20$17.80/sh4,310$76,718282,138 total
Footnotes (1)
  • [F1]Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -